#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophilia A with anti factor VIII Hypocalcaemia Oesophageal achalasia Waldenstrom's macroglobulinaemia Phaeochromocytoma Polyneuropathy Chronic kidney disease Neuroendocrine carcinoma of the skin Mantle cell lymphoma refractory Kawasaki's disease Duchenne muscular dystrophy gene carrier Diffuse large B-cell lymphoma recurrent Small intestine adenocarcinoma Colorectal adenocarcinoma Mucopolysaccharidosis III More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Diagnostics Cystic fibrosis lung – Treatment Rhabdomyosarcoma recurrent – Treatment Piriformis syndrome – Trials in Disease Friedreich’s ataxia – Trials in Disease Mantle cell lymphoma stage III – Life with Disease Alport’s syndrome – Treatment Angelman’s syndrome Testicular leiomyosarcoma – Basic Information Retinoblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kan-101 Crizanlizumab Satoreotide Tetraxetan Vinflunine Bp1.7881A Ibuprofen Sodium Dihydrate Olodaterol Maribavir L-Tyrosine Cisatracurium Besilate Mycophenolate Sodium Mps-102 A24110He VANDETANIB Avapritinib Ads-011 Vibostolimab Letetresgene Autoleucel Gsk3858279 Skin Autograft More therapies…

    Learn about Your Condition

    Adenocarcinoma pancreas Toxicity to various agents Endometrial cancer recurrent Brain cancer metastatic Periodontitis Agitation Lymphangiosarcoma Bone hypertrophy Neurofibromatosis Left ventricular failure Seizure Piriformis syndrome Metastases to peritoneum Breast cancer metastatic Candida infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mudyoe Ztmtqvzy Kkcbx 2vi Dkzcbopko 4skaf Hhlxvku

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Enlicitide and Rosuvastatin for Adults With High Cholesterol

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hyperlipidaemia
    Investigated Drugs:
    • Rosuvastatin Zinc
    Hungary Spain

  • A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    Croatia Czechia Hungary Romania Slovakia

  • A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Eltrombopag
    • Entecavir
    • Ianalumab
    Austria Belgium Czechia France Germany Hungary +5

  • A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    • Arteriosclerosis
    • Chronic kidney disease
    Investigated Drugs:
    • Ziltivekimab
    Belgium Bulgaria Croatia Czechia Denmark Germany +12

  • Study of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria France Germany Greece +8

  • Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Metformin Embonate
    • Dapagliflozin Propanediol
    Bulgaria Croatia Germany Greece Hungary Poland +3

  • Study of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Zasocitinib
    • Apremilast
    Bulgaria Czechia France Germany Greece Hungary +3

  • Study of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    Czechia Finland Hungary Italy Poland Slovakia +1

  • Study of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Belgium Croatia France Germany Greece Hungary +4

  • Study of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic obstructive pulmonary disease
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Bulgaria Czechia Germany Hungary Ireland Latvia +5
Previous Page
1 … 23 24 25 26 27 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!